Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06526546 · ClinicalTrials.gov registry record
ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 364
- Enrollment target
- 20
- Study locations
NCT06526546 is a study of Paroxysmal Atrial Fibrillation that has completed, run by Boston Scientific Corporation. The registered enrollment target is 364 participants, below the 844-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (57% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT06526546, a study of Paroxysmal Atrial Fibrillation, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 364 participants
- Enrollment target
- 20
- Study locations
Study Summary
The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.
Conditions Studied
Study Locations (20)
California
- Mills Peninsula Health Services - Burlingame
- Scripps Memorial Hospital - La Jolla
- University of California, San Francisco - San Francisco
Pennsylvania
- Doylestown Hospital - Doylestown
- Presbyterian University of Pennsylvania Medical Center - Philadelphia
- Pinnacle Health at Harrisburg Hospital - Wormleysburg
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
- Beth Israel Deaconess Medical Center - Boston
New York
- Mount Sinai, Icahn School of Medicine - New York
- Northwell Health - New York
Alabama
- Grandview Medical Center - Birmingham
Arizona
- Banner University Medical Center Phoenix - Phoenix
District of Columbia
- Washington Hospital Center - Washington D.C.
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 364 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2025-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06526546
The ClinicalTrials.gov registry entry for NCT06526546 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 364 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 844-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (57% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT06526546 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Pennsylvania, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06526546 about?
NCT06526546 is a clinical study titled "ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study". The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.
What is the current status of trial NCT06526546?
This trial is currently completed. The enrollment target is 364 participants. The study started on 2024-10-31. Estimated completion is 2025-12-08.
What conditions does trial NCT06526546 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
Who is sponsoring clinical trial NCT06526546?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06526546 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.